CNTN Seeking Patient Partners

Study Lead

Alicia Murdoch

CNTN Project Manager

Overview

The Capacity Building and Communications and Engagement Committees of the Canadian Nephrology Trials Network are looking for additional patient partners to join them! These committees each meet online for 1 hour every other month to discuss initiatives to support nephrology research in Canada. The committee aims are listed below.

We are seeking those with lived experience in nephrology care of all ages from all corners of the country. Honoraria is provided.

If you are interested in participating or would like more information about the work of these committees, please email Alicia Murdoch (amurdoch@cansolveckd.ca). You can also visit www.cntn.ca.

 

This committee aims to increase the number of people trained to conduct clinical trials in Canada by highlighting training resources, developing a mentorship program, encouraging more sites to participate in research and increasing the number of research ideas or questions developed by both patients and physicians.

 

 

 

 

This committee aims to recruit new patient partners, researchers and clinicians to the network and facilitate more collaboration with academic and non-academic sites across Canada. They are also developing a communications strategy to increase the exposure of the network in the Canadian and international research arena.

Eligibility

If you have lived experience in kidney disease, we would be happy to have you join our committee!

Type of Participation

Patient Partnership

Location

All provinces and territories

Related studies

  • Promoting shared decision making for people with advanced chronic kidney disease

    Overview:

    Study type: Focus Group

    August 8, 2024

  • Improving the Care and Experiences of Living Kidney Donors

    Overview: Seeking family physicians and transplant healthcare professionals for an online interview that will help develop tools to improve the experiences, care, and outcomes of living kidney donors.

    Study type: Interview

    July 25, 2024

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024